Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Briggs

Showing results (131-140 of 229) with videos related to

Pageof 23
Sort By:
Journal of Medical Screening|March 14, 2015
Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trialOliver Old, Paul Moayyedi, Sharon Love, et al.
Future Oncology (London, England)|September 1, 2025
Finding the right tool for the specific task: navigating RWE tools and checklistsRichard Willke, Paul Cottu, Andrew Briggs, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force reportScott D Ramsey, Richard J Willke, Henry Glick, et al.
Health Economics|September 26, 2024
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populationsDavid G Lugo-Palacios, Patrick Bidulka, Stephen O'Neill, et al.
ACS Applied Nano Materials|July 12, 2021
Examining Experimental Raman Mode Behavior in Mono- and Bilayer 2H-TaSe<sub>2</sub> via Density Functional Theory: Implications for Quantum Information ScienceSugata Chowdhury, Heather M Hill, Albert F Rigosi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 2, 2023
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods ManualAris Angelis, Martin Harker, John Cairns, et al.
International Journal of Cardiology|July 29, 2022
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?Martin R Cowie, Biykem Bozkurt, Javed Butler, et al.
The Lancet. Diabetes & Endocrinology|December 25, 2018
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetesYiqiao Xin, Andrew Davies, Louise McCombie, et al.
Wellcome Open Research|January 14, 2020
Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trialNicola McMeekin, Claudia Geue, Andrew Briggs, et al.
AIDS (London, England)|July 1, 2010
Expanding access to HAART: a cost-effective approach for treating and preventing HIVKarissa M Johnston, Adrian R Levy, Viviane D Lima, et al.
Pageof 23

Showing results (131-140 of 229) with videos related to

Sort By:
Pageof 23
Journal of Medical Screening|March 14, 2015
Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trialOliver Old, Paul Moayyedi, Sharon Love, et al.
Future Oncology (London, England)|September 1, 2025
Finding the right tool for the specific task: navigating RWE tools and checklistsRichard Willke, Paul Cottu, Andrew Briggs, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force reportScott D Ramsey, Richard J Willke, Henry Glick, et al.
Health Economics|September 26, 2024
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populationsDavid G Lugo-Palacios, Patrick Bidulka, Stephen O'Neill, et al.
ACS Applied Nano Materials|July 12, 2021
Examining Experimental Raman Mode Behavior in Mono- and Bilayer 2H-TaSe<sub>2</sub> via Density Functional Theory: Implications for Quantum Information ScienceSugata Chowdhury, Heather M Hill, Albert F Rigosi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 2, 2023
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods ManualAris Angelis, Martin Harker, John Cairns, et al.
International Journal of Cardiology|July 29, 2022
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?Martin R Cowie, Biykem Bozkurt, Javed Butler, et al.
The Lancet. Diabetes & Endocrinology|December 25, 2018
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetesYiqiao Xin, Andrew Davies, Louise McCombie, et al.
Wellcome Open Research|January 14, 2020
Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trialNicola McMeekin, Claudia Geue, Andrew Briggs, et al.
AIDS (London, England)|July 1, 2010
Expanding access to HAART: a cost-effective approach for treating and preventing HIVKarissa M Johnston, Adrian R Levy, Viviane D Lima, et al.
Pageof 23